Your browser version may not work well with NCBI's Web applications. More information here...
1: J Urol. 2004 Feb;171(2 Pt 2):S5-8; discussion S9.Links

Prostate cancer chemoprevention: an overview of United States trials.

Barqawi A, Thompson IM, Crawford ED.

Division of Urologic Oncolgy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

PURPOSE: We review the current status of clinical trials investigating the use of interventions designed to reduce the risk of prostate cancer. MATERIALS AND METHODS: A comprehensive review of the literature was conducted, which included the Ovid database and recent abstract proceedings from national meetings relevant to chemoprevention trials in prostate cancer. All clinical trials sponsored by the National Institutes of Health and National Cancer Institute in the United States were included. RESULTS: A total of 11 randomized controlled trials were found to be currently recruiting patients in the United States. These randomized controlled trials are designed to investigate the efficacy of a variety of agents ranging from dietary supplements to laboratory manufactured drugs, such as finasteride and cyclooxygenase-2 inhibitors, for the primary chemoprevention of prostate cancer. CONCLUSIONS: Chemoprevention of prostate cancer is currently being tested in a wide range of clinical trials. These studies have the potential to fundamentally alter the current approach to prostate cancer management.

PMID: 14713745 [PubMed - indexed for MEDLINE]

Related Articles

Patient Drug Information
  • Finasteride (Proscar®) Finasteride is used alone or in combination with other medications to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). Finasteride improves symptoms of BPH such as frequent and difficult urina...
    » read more ...